从2010年到2019年,肝硬化流行病学的变化:2019年全球疾病负担研究的结果
Shiyu Xiao1, Wenhui Xie2, Yinghui Zhang1
1Department of Gastroenterology, Sichuan Provincial People's Hospital, Chengdu, China.
Annals of medicine
|August 30, 2023
概括
全球肝硬化发病率从2010年至2019年略有上升,但死亡和DALYs下降. 非酒精性脂肪性肝病 (NAFLD) 已成为全球肝硬化负担快速增长的原因.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 全球健康 全球健康
- 流行病学 流行病学
背景情况:
- 肝硬化代表了全球健康的重大负担,往往是可以预防的.
- 了解它的流行病学和风险因素对于公共卫生干预至关重要.
研究的目的:
- 分析2010年至2019年肝硬化病的全球和区域负担.
- 确定各种病因对肝硬化发病率,死亡率和残疾调整寿命年 (DALYs) 的贡献.
主要方法:
- 利用了2019年全球疾病负担研究的数据.
- 根据年龄,性别,地区,病因和社会人口指数 (SDI) 估计的肝硬化负担.
- 使用年度百分比变化 (APC) 量化时间趋势.
主要成果:
- 在全球范围内,肝硬化发病率略有增加,而年龄标准化死亡率和DALY在2010年至2019年期间下降.
- 型肝炎是肝硬化负担的主要原因,但非酒精性脂肪肝 (NAFLD) 的发病率和死亡率增长最为显著.
- 肝硬化负担在男性中始终较高,低SDI国家死亡率和DALY率最高,中等SDI国家发病率最高.
结论:
- 尽管全球肝硬化发病率略有上升,但观察到与肝硬化相关的死亡和DALY显著减少.
- 非酒精性脂肪性肝病 (NAFLD) 是导致全球肝硬化负担迅速升级的一个因素.
更多相关视频
相关概念视频
Diseases of the Liver and Gallbladder
622
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
622
Esophageal Varices-II: Clinical Features and Management
94
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
94
Ultrasound II: Endoscopic Ultrasound and FibroScan
137
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
137
Esophageal Varices-I: Introduction
176
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
176
Gastritis-II: Pathophysiology
371
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
371
Prevalence and Incidence
623
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
623


